PPARβ/δ-dependent MSC metabolism determines their immunoregulatory properties
Open Access
- 10 July 2020
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-8
Abstract
Mesenchymal stem cell (MSC)-based therapy is being increasingly considered a powerful opportunity for several disorders based on MSC immunoregulatory properties. Nonetheless, MSC are versatile and plastic cells that require an efficient control of their features and functions for their optimal use in clinic. Recently, we have shown that PPARβ/δ is pivotal for MSC immunoregulatory and therapeutic functions. However, the role of PPARβ/δ on MSC metabolic activity and the relevance of PPARβ/δ metabolic control on MSC immunosuppressive properties have never been addressed. Here, we demonstrate that PPARβ/δ deficiency forces MSC metabolic adaptation increasing their glycolytic activity required for their immunoregulatory functions on Th1 and Th17 cells. Additionally, we show that the inhibition of the mitochondrial production of ATP in MSC expressing PPARβ/δ, promotes their metabolic switch towards aerobic glycolysis to stably enhance their immunosuppressive capacities significantly. Altogether, these data demonstrate that PPARβ/δ governs the immunoregulatory potential of MSC by dictating their metabolic reprogramming and pave the way for enhancing MSC immunoregulatory properties and counteracting their versatility.Keywords
Funding Information
- Agence Nationale pour la Recherche (ANR-18-CE18-0010-02)
- FONDECYT Iniciación (11160929)
- Fondecyt Regular (1170852)
- Programa de apoyo a la formación de redes internacionales (180211)
- Programa de Cooperación Científica ECOS-CONICYT (PC18S04-ECOS180032)
- Beca Doctorado Nacional 2014 RC-L (21141173)
- ECOS-Sud (C18S03)
- Fondation Arthritis
This publication has 17 references indexed in Scilit:
- PPARβ/δ directs the therapeutic potential of mesenchymal stem cells in arthritisAnnals of the Rheumatic Diseases, 2016
- Metabolic Reprograming in Macrophage PolarizationFrontiers in Immunology, 2014
- Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cellsStem Cell Research & Therapy, 2013
- Mesenchymal Stem Cells Repress Th17 Molecular Program through the PD-1 PathwayPLOS ONE, 2012
- Adipocyte-Derived Th2 Cytokines and Myeloid PPARδ Regulate Macrophage Polarization and Insulin SensitivityCell Metabolism, 2008
- PPARδ regulates multiple proinflammatory pathways to suppress atherosclerosisProceedings of the National Academy of Sciences, 2008
- PPARδ as a therapeutic target in metabolic diseaseFEBS Letters, 2007
- Role of AMP Kinase and PPARδ in the Regulation of Lipid and Glucose Metabolism in Human Skeletal MuscleJournal of Biological Chemistry, 2007
- Peroxisome proliferator-activated receptor δ promotes very low-density lipoprotein-derived fatty acid catabolism in the macrophageProceedings of the National Academy of Sciences, 2006
- Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptideBlood, 2003